These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7472417)

  • 1. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.
    Mackie K; Lai Y; Westenbroek R; Mitchell R
    J Neurosci; 1995 Oct; 15(10):6552-61. PubMed ID: 7472417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A second endogenous cannabinoid that modulates long-term potentiation.
    Stella N; Schweitzer P; Piomelli D
    Nature; 1997 Aug; 388(6644):773-8. PubMed ID: 9285589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
    Twitchell W; Brown S; Mackie K
    J Neurophysiol; 1997 Jul; 78(1):43-50. PubMed ID: 9242259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of a peripheral receptor for cannabinoids.
    Munro S; Thomas KL; Abu-Shaar M
    Nature; 1993 Sep; 365(6441):61-5. PubMed ID: 7689702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cyclic AMP in the actions of cannabinoid receptors.
    Childers SR; Deadwyler SA
    Biochem Pharmacol; 1996 Sep; 52(6):819-27. PubMed ID: 8781498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.
    Cadas H; Gaillet S; Beltramo M; Venance L; Piomelli D
    J Neurosci; 1996 Jun; 16(12):3934-42. PubMed ID: 8656287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
    Mackie K; Devane WA; Hille B
    Mol Pharmacol; 1993 Sep; 44(3):498-503. PubMed ID: 8371711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
    Mechoulam R; Ben-Shabat S; Hanus L; Ligumsky M; Kaminski NE; Schatz AR; Gopher A; Almog S; Martin BR; Compton DR
    Biochem Pharmacol; 1995 Jun; 50(1):83-90. PubMed ID: 7605349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
    Galiègue S; Mary S; Marchand J; Dussossoy D; Carrière D; Carayon P; Bouaboula M; Shire D; Le Fur G; Casellas P
    Eur J Biochem; 1995 Aug; 232(1):54-61. PubMed ID: 7556170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay.
    Andersen HK; Vardakas DG; Lamothe JA; Perault TEA; Walsh KB; Laprairie RB
    Sci Rep; 2024 Aug; 14(1):18314. PubMed ID: 39112591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local activation of CB1 receptors by synthetic and endogenous cannabinoids dampens burst firing mode of reticular thalamic nucleus neurons in rats under ketamine anesthesia.
    Aguirre-Rodríguez CA; Delgado A; Alatorre A; Oviedo-Chávez A; Martínez-Escudero JR; Barrientos R; Querejeta E
    Exp Brain Res; 2024 Sep; 242(9):2137-2157. PubMed ID: 38980339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level.
    Spicarova D; Palecek J
    Physiol Res; 2024 Aug; 73(S1):S435-S448. PubMed ID: 38957948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Development of Cannabinoids as Therapeutic Agents in the United States.
    Murray CH; Gannon BM; Winsauer PJ; Cooper ZD; Delatte MS
    Pharmacol Rev; 2024 Aug; 76(5):915-955. PubMed ID: 38849155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 Cannabinoid Receptor is a Target for Neuroprotection in Light Induced Retinal Degeneration.
    Soliño M; Larrayoz IM; López EM; Rey-Funes M; Bareiro M; Loidl CF; Girardi E; Caltana L; Brusco A; Martínez A; López-Costa JJ
    Adv Drug Alcohol Res; 2022; 2():10734. PubMed ID: 38390616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Cannabinoids in Oral Cancer.
    Cretu B; Zamfir A; Bucurica S; Scheau AE; Savulescu Fiedler I; Caruntu C; Caruntu A; Scheau C
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges.
    Hassan FU; Liu C; Mehboob M; Bilal RM; Arain MA; Siddique F; Chen F; Li Y; Zhang J; Shi P; Lv B; Lin Q
    Front Immunol; 2023; 14():1285052. PubMed ID: 38111585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells.
    Cherkasova V; Ilnytskyy Y; Kovalchuk O; Kovalchuk I
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Cannabinoid Signaling in Cardiovascular Function and Ischemic Injury.
    Rorabaugh BR; Guindon J; Morgan DJ
    J Pharmacol Exp Ther; 2023 Dec; 387(3):265-276. PubMed ID: 37739804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in acute delta-9-tetrahydrocannabinol (Δ
    Lulek CF; Maulik M; Mitra S; Guindon J; Morgan DJ; Henderson-Redmond AN
    Psychopharmacology (Berl); 2023 Sep; 240(9):1987-2003. PubMed ID: 37516707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of cannabinoid tolerance.
    Piscura MK; Henderson-Redmond AN; Barnes RC; Mitra S; Guindon J; Morgan DJ
    Biochem Pharmacol; 2023 Aug; 214():115665. PubMed ID: 37348821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.